InvestorsHub Logo
Followers 219
Posts 247348
Boards Moderated 2
Alias Born 04/06/2006

Re: Tuff-Stuff post# 554845

Monday, 12/22/2014 7:06:40 AM

Monday, December 22, 2014 7:06:40 AM

Post# of 648882
<>BCRX 12% low volume>FDA clears BioCryst flu med

The FDA approves BioCryst Pharmaceuticals' (NASDAQ:BCRX) Rapivab (peramir injection) for the treatment of adult (18 years and older) patients with acute uncomplicated influenza who have been symptomatic for no more than two days.
Rapivab is a neuraminidase inhibitor that is administered as a single 600 mg dose intravenously over 15 to 30 minutes.

Pray for A Pain Free Day!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.